The Brain Foundation has announced a request for proposals (RFP) to support translational research aimed at developing effective treatments for individuals with autism spectrum disorders (ASD). The initiative seeks to fund projects that can lead to FDA-approved treatments and improve the standard of care for co-morbidities associated with autism.
Funding Details
In 2025, the Brain Foundation will award grants of up to $90,000 per year for a maximum of two years. These grants are intended to support treatment trials, encompassing pre-clinical drug studies, Phase I/II clinical treatment trials, human treatment studies, and animal or organoid studies. The primary focus is to evaluate the efficacy of new compounds and repurposed drugs in treating the disabling symptoms of autism.
Research Priorities
The foundation places a higher priority on human studies, reflecting a commitment to translating research findings into tangible benefits for individuals with ASD. The research should aim to improve the functioning of individuals with neuro-developmental disorders, including autism spectrum disorders.
Eligibility Criteria
Eligible applicants include Principal Investigators (PIs) associated with research institutions or private enterprises. These organizations must be capable of accepting grants from a nonprofit entity and obtaining Institutional Review Board (IRB) approval for their work. This requirement ensures that all research activities adhere to ethical and regulatory standards.
Application Information
Interested applicants are encouraged to review the complete program guidelines and application instructions available on the Brain Foundation website. The deadline for submitting proposals is January 20, 2025. This funding opportunity represents a significant step towards advancing the development of effective therapeutics for autism and improving the lives of those affected by the condition.
